U.S. Semiconductors Stock News

NYSE:PRLB
NYSE:PRLBMachinery

Proto Labs (PRLB) Valuation Check As Record Revenue And EPS Guidance Beat Expectations

Proto Labs (PRLB) is back in focus after reporting record quarterly revenue, 12.1% year over year revenue growth, and earnings that came in ahead of market expectations, along with guidance that topped EPS forecasts. See our latest analysis for Proto Labs. Despite the upbeat earnings news, Proto Labs has had a mixed share price run, with a 12.71% 90-day share price return and an 11.04% year-to-date share price return. The 1-year total shareholder return sits at 61.12% and the 3-year total...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

Is It Too Late To Consider Masimo (MASI) After This Year’s 40% Rally?

If you are wondering whether Masimo at around US$177.87 is offering value or asking you to pay up for quality, this breakdown will help you frame that question clearly. The stock has been relatively steady over the last week with a 0.5% decline, modestly higher over 30 days with a 1.4% gain, and much stronger year to date with a 39.6% return, compared with a 6.1% return over the past year and a 24.2% decline over five years. Recent headlines have focused on Masimo's position in medical...
NasdaqGM:PSNY
NasdaqGM:PSNYAuto

Volvo Equity Swap And US Production Shift Recast Polestar Risk Profile

Volvo Cars has converted its outstanding shareholder loans to Polestar Automotive Holding UK (NasdaqGM:PSNY) into equity, changing the mix of Polestar’s capital structure. The two companies also agreed to concentrate future manufacturing of the Polestar 3 in the U.S., expanding their existing production collaboration. For investors watching NasdaqGM:PSNY, these moves come against a backdrop of a share price at $18.42 and a long term track record that includes a 41.5% decline over the past...
NYSE:TEX
NYSE:TEXMachinery

Assessing Terex (TEX) Valuation After Recent Share Price Cooling

Terex stock: context for recent performance Terex (TEX) has drawn fresh attention after recent share price moves, with the stock up 0.8% over the past day, showing a 14% decline over the past month and a 10.7% gain over the past 3 months. See our latest analysis for Terex. That 7.7% 1 day share price return sits against a 14.1% 30 day share price decline and a 57.4% 1 year total shareholder return, which suggests momentum has cooled recently after a strong run for longer term holders. If...
NYSE:CDE
NYSE:CDEMetals and Mining

Is It Too Late To Consider Coeur Mining (CDE) After A 236% One Year Surge?

Wondering if Coeur Mining at around US$18.77 is still giving you fair value, or if the big moves are already priced in? This article breaks down what the current market price might be implying. The stock has produced a 236.4% return over the last year and 342.7% over 3 years, while more recently showing a 2.5% return over 7 days, a 30.9% decline over 30 days, and a 7.0% return year to date. This mix of results may signal changing expectations around risk and reward. Recent coverage has...
NYSE:WY
NYSE:WYSpecialized REITs

How Projected Q1 2026 Profit Decline vs. 2026–27 Outlook Will Impact Weyerhaeuser (WY) Investors

Weyerhaeuser recently drew investor attention ahead of its past Q1 2026 earnings release, as analysts projected a sharp year-over-year drop in funds from operations and weaker quarterly profit. At the same time, analysts’ expectations for stronger funds from operations and earnings per share in fiscal 2026 and 2027 have raised questions about how short-term pressure might contrast with the longer-term outlook for the timber REIT. Next, we’ll examine how the expected Q1 2026 profit drop and...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Signatera Data in Older Breast Cancer Patients Could Be A Game Changer For Natera (NTRA)

Natera, Inc. recently reported Clinical Cancer Research data showing its Signatera molecular residual disease test helped older women with early-stage ER+/HER2- breast cancer use primary endocrine therapy instead of surgery, with testing done at baseline and then every 3–6 months. The study’s ability to identify patients who remained progression-free and to detect molecular signs of tumor progression before imaging highlights Signatera’s potential role in personalized treatment decisions for...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Garmin (GRMN) Valuation Check After Recent Share Price Swings And Premium P/E Multiple

Garmin (GRMN) is on investor radars after recent share price swings, with the stock up about 14% over the past 3 months but showing a decline over the past month alongside mixed short-term returns. See our latest analysis for Garmin. At a share price of $232.01, Garmin’s short term momentum has cooled, with a 30 day share price return decline of 8.23%, even as the 90 day share price return of 14.38% and 3 year total shareholder return of 145.35% point to stronger performance over a longer...
NYSE:CRS
NYSE:CRSAerospace & Defense

Assessing Carpenter Technology (CRS) Valuation After Powerful Multi‑Year Shareholder Returns

Carpenter Technology (CRS) is back on investors’ radar after recent share price moves, with the stock closing at $394.15. That level is drawing fresh interest in its long term return profile. See our latest analysis for Carpenter Technology. The recent 6.3% 1 day share price return sits against a quieter 30 day share price return and a stronger 90 day gain of 25.2%, while the 1 year total shareholder return is very large and the 3 and 5 year total shareholder returns are each more than 8x...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

Does TMC’s Brownsville Hub Plan and New Shelves Change The Bull Case For TMC (TMC)?

TMC the metals company Inc. recently filed multiple shelf registrations, including ESOP-related offerings totaling roughly 21.1 million common shares and a broader universal shelf covering common and preferred shares, debt, warrants and units, soon after reporting a full-year 2025 net loss of US$319.84 million. At the same time, TMC highlighted progress toward a U.S. commercial production permit, outlined plans for a large processing and refining hub at the Port of Brownsville in Texas, and...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

A Look At Recursion Pharmaceuticals (RXRX) Valuation As Investor Narratives Diverge

Why Recursion Pharmaceuticals is on investors’ radar today Recursion Pharmaceuticals (RXRX) has attracted attention after recent trading, with the share price at $3.07 and returns showing mixed performance over the past week, month and past 3 months. For investors tracking high risk biotech names, the company’s clinical stage drug discovery pipeline, revenue of $74.681 million, and market cap of about $1.5b provide context for assessing whether the current level looks appealing or...
NYSE:TDG
NYSE:TDGAerospace & Defense

How Investors May Respond To TransDigm Group (TDG) Beating Q1 Revenue And Operating Income Expectations

In the past quarter, TransDigm Group reported a 13.9% year-on-year revenue increase and exceeded analyst expectations on both sales and adjusted operating income, which management described as a solid start to its 2026 fiscal year. This performance highlights the breadth of TransDigm’s installed base, with its proprietary components touching nearly all in-service aircraft across commercial and military aviation. Next, we’ll examine how TransDigm’s stronger-than-expected revenue and operating...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Has Axon Enterprise (AXON) Pulled Back Enough After Recent Product Rollouts And Contract Wins

If you are wondering whether Axon Enterprise at around US$424.69 still offers value or has run ahead of itself, you are not alone. The stock has recently seen a 7% decline over the last week, a 21.7% decline over the last month and a 24.6% decline year to date, even though the 1 year return sits at 21.5% and the 3 year and 5 year returns are 90.4% and 191.7% respectively. Recent headlines around Axon have focused on product rollouts, contract wins with law enforcement agencies and ongoing...
NasdaqGS:HON
NasdaqGS:HONIndustrials

The Bull Case For Honeywell International (HON) Could Change Following New U.S. Defense And AI Deals

In late March 2026, Honeywell announced a multi-year supplier framework agreement with the U.S. Department of War to expand production of critical defense technologies, alongside a large debt tender and a new AI-powered video and access-control collaboration between Honeywell Building Automation and Rhombus initially focused on North America. Taken together, these moves highlight Honeywell’s push to modernize its balance sheet while deepening exposure to defense demand and cloud-based,...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

A Look At Grab Holdings (GRAB) Valuation After Launch Of Ai.R Autonomous Ride Service

Grab Holdings (GRAB) stock is drawing attention after the company and WeRide started public operations of the Ai.R autonomous ride service in Punggol, opening a new chapter for Grab’s mobility platform. See our latest analysis for Grab Holdings. Despite the Ai.R rollout and recent corporate updates, momentum in Grab Holdings' share price has been weak. The 30 day share price return is 12.44% and the year to date share price return is 27.95%, while the 1 year total shareholder return of 20.61%...
NYSE:UPS
NYSE:UPSLogistics

A Look At United Parcel Service’s Valuation As Dividend Freeze And Customer Mix Shift Take Shape

Dividend freeze and business shift put UPS in focus United Parcel Service (UPS) is back on investors’ radar after CFO Brian Dykes outlined a 2026 dividend freeze, along with a move away from a low-margin Amazon segment to target higher-value customers. See our latest analysis for United Parcel Service. UPS shares closed at US$98.38 after a 3.61% 1-day share price return. However, the 30-day share price return of 15.16% and 1-year total shareholder return decline of 3.80% show that recent...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Should Dollar Tree’s (DLTR) New Term Loan And Supply Chain Spend Require Action From Investors?

Dollar Tree recently entered into a US$500 million term loan credit facility maturing in March 2029, with interest tied to the Term SOFR Rate plus 1.00%, flexible prepayment, and covenants linked to leverage and fixed charge coverage ratios. The new financing, combined with ongoing investment in rebuilt and newly acquired distribution centers and cloud-based supply chain technology, underscores management’s emphasis on upgrading infrastructure and inventory management capabilities. We’ll now...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Rumble (RUM) Valuation Check As New CFO With AI And Cloud Experience Joins The Team

Why Rumble’s CFO change matters for investors Rumble (RUM) is reshaping its senior team, bringing in former Intel executive Mike Masci as CFO on March 31, 2026, while outgoing CFO Brandon Alexandroff shifts into an advisor role. For you as an investor, this type of leadership change can affect how the company balances cash needs, growth investments, and potential capital allocation decisions, including its AI and cloud infrastructure plans. See our latest analysis for Rumble. Rumble’s latest...
NasdaqGS:RMBS
NasdaqGS:RMBSSemiconductor

Rambus (RMBS) Insider Stock Sales: What Do They Signal About Its AI Memory Strategy?

In March 2026, Rambus Inc. insiders, including executives Seraphin Luc and John Shinn, sold more than US$4.60 million of stock, prompting renewed scrutiny of management’s intentions and timing. This wave of insider selling has become a focal point for investors already watching semiconductor sector weakness and questioning how closely leadership’s actions align with Rambus’s long-term positioning in AI-focused memory solutions. We’ll now examine how this recent insider selling flurry...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Is It Time To Reassess Ascendis Pharma (ASND) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether Ascendis Pharma's share price still offers value after a strong run, the key is to look closely at what the current valuation actually reflects. The stock last closed at US$228.73, with returns of 6.1% over 7 days, a 2.0% decline over 30 days, 7.2% year to date, 51.0% over 1 year, 220.2% over 3 years and 73.7% over 5 years. Recent price moves have come alongside ongoing attention on Ascendis Pharma's pipeline progress and funding position, as investors reassess...
NasdaqGS:WBTN
NasdaqGS:WBTNInteractive Media and Services

Global CANVAS Rollout And AI Tools Could Be A Game Changer For WEBTOON Entertainment (WBTN)

WEBTOON Entertainment Inc. recently announced that its regional CANVAS user-generated content services will be unified into a single global platform in 2026, supporting distribution in seven languages and introducing expanded creator monetization tools, analytics, and AI-assisted translation. This move signals an effort to lower language and distribution barriers for creators while deepening reader personalization, potentially increasing creator engagement and strengthening WEBTOON’s...
NasdaqGS:KMB
NasdaqGS:KMBHousehold Products

How Investors Are Reacting To Kimberly-Clark (KMB) Slowing Sales, Weaker Cash Flow And Suzano JV Review

Recently, Deutsche Bank reiterated a Hold rating on Kimberly-Clark while Britain’s competition regulator began a phase 1 review of its US$3.40 billion Suzano joint venture, with a decision expected by May 28. At the same time, modest 2.5% organic sales growth and a five‑percentage‑point drop in free cash flow margin have raised fresh questions about Kimberly-Clark’s core profitability and capital needs. We’ll now examine how concerns over slowing organic sales and weaker free cash flow...
NYSE:XIFR
NYSE:XIFRRenewable Energy

A Look At XPLR Infrastructure (XIFR) Valuation After Its US$300 Million Shelf Registration Filing

Capital raise potential and what it could mean for XPLR Infrastructure (XIFR) XPLR Infrastructure (XIFR) has filed a US$300 million shelf registration for its common units, giving the partnership flexibility to issue equity as funding needs or investment plans emerge. See our latest analysis for XPLR Infrastructure. The shelf filing comes as XIFR’s share price sits at US$10.62, with a 1 day share price return of 4.94% and a 1 year total shareholder return of 13.83%. The 3 year total...
NasdaqCM:MARA
NasdaqCM:MARASoftware

How MARA’s US$1.1 Billion Bitcoin Sale To Retire Debt Has Changed Its Investment Story (MARA)

MARA Holdings recently sold 15,133 Bitcoin between March 4 and March 25, 2026, raising about US$1.10 billion to repurchase roughly US$1.00 billion of its 2030 and 2031 convertible notes, cutting its Bitcoin holdings by around 28%. This large balance-sheet move, described by one hedge fund CIO as “distressed selling,” raises fresh questions about financial flexibility and sector-wide pressures in Bitcoin mining. Next, we’ll examine how this sizable Bitcoin liquidation and debt reduction...